latest health care news

06.07.20

First patient receives blood plasma treatment at Guy’s and St Thomas’ NHS FT

As part of a major ongoing coronavirus clinical trial, Guy’s and St Thomas’ NHS Foundation Trust has given its first patient an experimental blood plasma treatment.

The treatment, known as convalescent plasma, is being tested for patients who are severely ill with Covid-19 as part of the national priority trial REMAP-CAP – an international trial, supported by the NIHR, which is testing different potential treatments for the virus.

Convalescent plasma treatments have previously shown to have a positive impact when they were used during the 2002 SARS outbreak to treat a different coronavirus.

As one of England’s top research trusts, Guy’s and St Thomas’ have been playing a leading role in research efforts to identify and safely test Covid-19 treatments and diagnostics in England.

Co-led by Dr Manu Shankar-Hari, a consultant in Intensive Care Medicine at Guy’s and St Thomas’ – who is also an NIHR Clinician Scientist and Reader at King’s College London – the trial is also utilising expertise from colleagues at NHS Blood and Transplant as well as the University of Cambridge.

The patient to first receive the treatment was admitted to St Thomas’ Hospital at the end of April with coronavirus symptoms and saw their condition deteriorate significantly enough to require admission to the Intensive Care Unit (ICU) where they were approached to take part in the trial.

The patient was discharged from hospital on May 15 and continues to be recovering well at home.

Talking of this milestone for the trial, Dr Shankar-Hari said: “Convalescent plasma is a promising treatment that could help patients whose bodies aren’t producing enough antibodies to curb the disease.

“This trial will help us understand whether the treatment should be used more widely to treat Covid-19.

“We are incredibly grateful to all the patients who are taking part in our Covid-19 trials and to their families. At a difficult time for them, our patients are taking part in studies that will help us to understand more about how to treat the condition.”

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

featured articles

View all News

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us throu more > more last word articles >

health service focus

View all News

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental ... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Bei... more >

interviews

Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

24/10/2019Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

Today, speaking at the Royal College of General Practitioners (RCGP) annual... more >

the scalpel's daily blog

Investing in people to reap the full benefits of data in the NHS

03/08/2020Investing in people to reap the full benefits of data in the NHS

Adam Mayer, Senior Manager, Qlik Data has the power to drastically improve patient care delivery within our healthcare services. From managing key operational issues... more >
read more blog posts from 'the scalpel' >